VJHemOnc is committed to improving our service to you

EHA 2020 | Relative dose intensity in older DLBCL patients

VJHemOnc is committed to improving our service to you

Raúl Córdoba

Raul Cordoba, MD, PhD of University Hospital Fundación Jiménez Díaz, Madrid, Spain, discusses impact of relative dose intensity on survival in elderly diffuse large B-cell lymphoma (DLBCL) patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter